Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
doi: 10.3389/fimmu.2020.01965 Summary Keywords systemic lupus erythematosus, chimeric antigen receptor T-cell, CD19, BCMA, therapeutic strategy, clinical implications Citation Zhou J, Lei B, Shi F, Luo X, Wu K, Xu Y, Zhang Y, Liu R, Wang H, Zhou J and He X (2024) CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives
Shingu and Nobunaga 1984
The old adage about prices too good to be true applies particularly in markets lacking regulatory oversight
A growing body of preclinical research continues to explore its mechanisms and applications, including emerging work on neuroprotective effects and potential roles in spinal cord injury recovery
US$ 22.49
US$ 22.83
US$ 28.49
US$ 29.55
US$ 25.33
US$ 27.98
